(port 1) on or about (b)(6) 2019, plaintiff underwent placement of an angiodynamics vortex product at university of iowa.The device was implanted for the purpose of ongoing red cell exchanges and vein access.On or about (b)(6) 2022, plaintiff presented herself to the emergency department at (b)(6) with complaints of pleuritic chest wall pain.Plaintiff was also found to be febrile and therefore was transferred to mary greeley medical center in ames, iowa.Upon being admitted at (b)(6) medical center, plaintiff's blood cultures were drawn and were persistently positive.Plaintiff's medical team determined that the vortex was the source of the infection and that the defective port had to be removed.On or about (b)(6) 2022, plaintiff's defective port was removed by dr.(b)(6) at (b)(6) medical center in (b)(6).(port 2) on or about (b)(6) 2022, plaintiff underwent placement of an additional angiodynamics vortex product, reference number lvtx5213, lot number 5730316.The device was implanted by (b)(6) , m.D., at (b)(6) in (b)(6) , for ongoing red cell exchanges and vein access.On or about (b)(6) 2023, plaintiff's blood cultures were drawn and were positive for staph aureus.Plaintiff's medical team determined that the vortex was the source of plaintiff's infection and that the defective device had to be removed.On or about (b)(6) 2023, plaintiff presented herself to(b)(6) for port removal.After multiple defective devices, plaintiff made the decision to not have another port implanted.As a result of having the vortex implanted, plaintiff is alleging significant mental and physical pain and suffering, has undergone additional surgeries, and has suffered financial or economic loss, including, but to limited to, obligations for medical services and expenses.
|